Association of vitamin K status with adiponectin and body composition in healthy subjects: Uncarboxylated osteocalcin is not associated with fat mass and body weight

British Journal of Nutrition

Volumn 108, Issue 6, 2012, Pages 1017-1024

  Knapen, Marjo H J ^a   Schurgers, Leon J ^b   Shearer, Martin J ^c   Newman, Paul ^d   Theuwissen, Elke ^a   Vermeer, Cees ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Adiponectin; Body composition; Osteocalcin; Vitamin K

Indexed keywords

ADIPONECTIN; MENAQUINONE 7; MENATETRENONE; OSTEOCALCIN; PLACEBO; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADIPONECTIN; ADIPOSITY; ADULT; AGED; BODY COMPOSITION; BODY WEIGHT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAMIN K; VITAMIN K DEFICIENCY; YOUNG ADULT;

EID: 84866139256     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451100626X     Document Type: Article

References (37)

1. Lee NK, Sowa H, Hinoi E, et al. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469.
2. Ferron M, Hinoi E, Karsenty G, et al. (2008) Osteocalcin differentially regulates b cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105, 5266-5270.
3. Berkner KL & Runge KW (2004) The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2, 2118-2132.
4. 2) and bone quality in the treatment of postmeno-pausal osteoporosis. Nutr Rev 64, 509-517.
5. 1 and natto-derived menaquinone-7. Blood 109, 3279-3283.
6. Booth SL, Martini L, Peterson JW, et al. (2003) Dietary phyl-loquinone depletion and repletion in older women. J Nutr 133, 2565-2569.
7. Vermeer C, Shearer MJ, Zittermann A, et al. (2004) Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 43, 325-335.
8. Binkley NC, Krueger DC, Kawahara TN, et al. (2002) A high phylloquinone intake is required to achieve maximal osteo-calcin gamma-carboxylation. Am J Clin Nutr 76, 1055-1060.
9. Iwamoto J, Sato Y, Takeda T, et al. (2009) High-dose vitamin K supplementation reduces fracture incidence in postmeno-pausal women: a review of the literature. Nutr Res 29, 221-228.
10. Sakamoto N, Kimura M, Hiraike H, et al. (1995) Changes of K vitamins in portal and femoral venous plasma of rats after oral administration of phylloquinone and menaquinone-4. Int J Vitam Nutr Res 65, 105-110.
11. Sakamoto N, Nishiike T, Iguchi H, et al. (1999) Relationship between acute insulin response and vitamin K intake in healthy young male volunteers. Diabetes Nutr Metab 12, 37-41.
12. Sakamoto N, Nishiike T, Iguchi H, et al. (2000) Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin Nutr 19, 259-263.
13. Yoshida M, Booth S, Meigs J, et al. (2008) Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 88, 210-215.
14. Yoshida M, Jacques P, Meigs J, et al. (2008) Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 31, 2092-2096.
15. Kumar R, Binkley N & Vella A (2010) Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 92, 1528-1532.
16. Shea MK, Booth SL, Gundberg CM, et al. (2010) Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women. J Nutr 140, 1029-1034.
17. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18, 963-972.
18. 2 (menaquinone-4) supplementation on body composition and serum parameters in rats. Bone 48, 1036-1042.
19. Sokoll LJ, Booth SL, Davidson KW, et al. (1998) Diurnal variation in total and undercarboxylated osteocalcin: influence of increased dietary phylloquinone. Calcif Tissue Int 62, 447-452.
20. Bugel S, Sorensen AD, Hels O, et al. (2007) Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. Br J Nutr 97, 373-380.
21. Knapen MH, Hellemons-Boode BS, Langenberg-Ledeboer M, et al. (2000) Effect of oral anticoagulant treatment on markers for calcium and bone metabolism. Haemostasis 30, 290-297.
22. Schurgers LJ, Shearer MJ, Hamulyak K, et al. (2004) Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 104, 2682-2689.
23. Yasui T, Uemura H, Umino Y, et al. (2006) Undercarboxy-lated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days. Menopause 13, 314-322.
24. 3 plus calcium on the bone health of older women. J Bone Miner Res 22, 509-519.
25. Binkley NC, Krueger DC, Engelke JA, et al. (2000) Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 72, 1523-1528.
26. Ferron M, Wei J, Yoshizawa T, et al. (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296-308.
27. Fulzele K, Riddle RC, DiGirolamo DJ, et al. (2010) Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142, 309-319.
28. Rached M-T, Kode A, Silva B, et al. (2010) FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 120, 357-368.
29. Ziemke F & Mantzoros C (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91, S258-S261.
30. Hwang Y-C, Jeong I-K, Ahn KJ, et al. (2009) The uncarboxy-lated form of osteocalcin is associated with improved glucose tolerance and enhanced b-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25, 768-772.
31. Fernandez-Real J, Izquierdo M, Ortega F, et al. (2009) The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94, 237-245.
32. Shea MK, Gundberg CM, Meigs JB, et al. (2009) Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 90, 1230-1235.
33. Prats-Puig A, Mas-Parareda M, Riera-Prez E, et al. (2010) Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 33, 661-663.
34. Ueland T, Fougner S, Godang K, et al. (2010) Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly. J Clin Endocrinol Metab 95, 361-368.
35. Kanazawa I, Yamaguchi T, Yamauchi M, et al. (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22, 187-194.
36. Takeuchi Y, Suzawa M, Fukumoto S, et al. (2000) Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27, 769-776.
37. Shearer MJ & Newman P (2008) Metabolism and cell biology of vitamin K. Thromb Haemost 100, 530-547.